报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 17:12:36
Documents
29
Period of Report
2026-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits
Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)
EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42121 | Film No.: 261508919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov